Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

A prospective surveillance study for multidrug-resistant bacteria colonization in hospitalized patients at a Thai University Hospital.

Rattanaumpawan P, Choorat C, Takonkitsakul K, Tangkoskul T, Seenama C, Thamlikitkul V.

Antimicrob Resist Infect Control. 2018 Aug 20;7:102. doi: 10.1186/s13756-018-0393-2. eCollection 2018.

2.

A noninferiority cluster-randomized controlled trial on antibiotic postprescription review and authorization by trained general pharmacists and infectious disease clinical fellows.

Rattanaumpawan P, Upapan P, Thamlikitkul V.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1154-1162. doi: 10.1017/ice.2018.198. Epub 2018 Aug 29.

PMID:
30156171
3.

Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand.

Ngamprasertchai T, Boonyasiri A, Charoenpong L, Nimitvilai S, Lorchirachoonkul N, Wattanamongkonsil L, Thamlikitkul V.

Infect Drug Resist. 2018 Aug 20;11:1219-1224. doi: 10.2147/IDR.S169939. eCollection 2018.

4.

Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection.

Wangchinda W, Pati N, Maknakhon N, Seenama C, Tiengrim S, Thamlikitkul V.

Antimicrob Resist Infect Control. 2018 Jul 17;7:84. doi: 10.1186/s13756-018-0375-4. eCollection 2018.

5.

Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand.

Eiamphungporn W, Yainoy S, Jumderm C, Tan-Arsuwongkul R, Tiengrim S, Thamlikitkul V.

J Glob Antimicrob Resist. 2018 Dec;15:32-35. doi: 10.1016/j.jgar.2018.06.007. Epub 2018 Jun 20.

PMID:
29935331
6.

Evaluation of the Rapid Polymyxin NP test for detection of colistin susceptibility in Enterobacteriaceae isolated from Thai patients.

Yainoy S, Hiranphan M, Phuadraksa T, Eiamphungporn W, Tiengrim S, Thamlikitkul V.

Diagn Microbiol Infect Dis. 2018 Oct;92(2):102-106. doi: 10.1016/j.diagmicrobio.2018.05.009. Epub 2018 May 16.

PMID:
29884562
7.

Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents.

Son S, Thamlikitkul V, Chokephaibulkit K, Perera J, Jayatilleke K, Hsueh PR, Lu CY, Balaji V, Moriuchi H, Nakashima Y, Lu M, Yang Y, Yao K, Kim SH, Song JH, Kim S, Kim MJ, Heininger U, Chiu CH, Kim YJ.

Clin Microbiol Infect. 2018 Apr 22. pii: S1198-743X(18)30351-3. doi: 10.1016/j.cmi.2018.04.013. [Epub ahead of print]

PMID:
29689428
8.

Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii.

Lomovskaya O, Sun D, Rubio-Aparicio D, Nelson KJ, Thamlikitkul V, Dudley MN, Redell MA.

Int J Antimicrob Agents. 2018 Sep;52(3):404-406. doi: 10.1016/j.ijantimicag.2018.04.006. Epub 2018 Apr 14.

PMID:
29665446
9.

Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach.

Pulcini C, Binda F, Lamkang AS, Trett A, Charani E, Goff DA, Harbarth S, Hinrichsen SL, Levy-Hara G, Mendelson M, Nathwani D, Gunturu R, Singh S, Srinivasan A, Thamlikitkul V, Thursky K, Vlieghe E, Wertheim H, Zeng M, Gandra S, Laxminarayan R.

Clin Microbiol Infect. 2019 Jan;25(1):20-25. doi: 10.1016/j.cmi.2018.03.033. Epub 2018 Apr 3.

PMID:
29625170
10.

Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia.

Sirijatuphat R, Sripanidkulchai K, Boonyasiri A, Rattanaumpawan P, Supapueng O, Kiratisin P, Thamlikitkul V.

PLoS One. 2018 Jan 3;13(1):e0190132. doi: 10.1371/journal.pone.0190132. eCollection 2018.

11.

Population Pharmacokinetics of Polymyxin B.

Manchandani P, Thamlikitkul V, Dubrovskaya Y, Babic JT, Lye DC, Lee LS, Tam VH.

Clin Pharmacol Ther. 2018 Sep;104(3):534-538. doi: 10.1002/cpt.981. Epub 2018 Jan 8.

PMID:
29238962
12.

Systematic review of electronic surveillance of infectious diseases with emphasis on antimicrobial resistance surveillance in resource-limited settings.

Rattanaumpawan P, Boonyasiri A, Vong S, Thamlikitkul V.

Am J Infect Control. 2018 Feb;46(2):139-146. doi: 10.1016/j.ajic.2017.08.006. Epub 2017 Oct 10.

PMID:
29029814
13.

Reply to Corona and Cattaneo.

Nation RL, Garonzik SM, Thamlikitkul V, Giamarellos-Bourboulis EJ, Forrest A, Paterson DL, Li J, Silveira FP.

Clin Infect Dis. 2017 Sep 1;65(5):870-871. doi: 10.1093/cid/cix390. No abstract available.

14.

Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients.

Forrest A, Garonzik SM, Thamlikitkul V, Giamarellos-Bourboulis EJ, Paterson DL, Li J, Silveira FP, Nation RL.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01367-17. doi: 10.1128/AAC.01367-17. Print 2017 Nov.

15.

Individual feedback to reduce inappropriate antimicrobial prescriptions for treating acute upper respiratory infections in an outpatient setting of a Thai university hospital.

Rattanaumpawan P, Chuenchom N, Thamlikitkul V; Siriraj Antimicrobial Stewardship Program.

J Glob Antimicrob Resist. 2018 Mar;12:11-14. doi: 10.1016/j.jgar.2017.08.015. Epub 2017 Sep 5.

PMID:
28887290
16.

Progress towards antimicrobial resistance containment and control in Indonesia.

Parathon H, Kuntaman K, Widiastoety TH, Muliawan BT, Karuniawati A, Qibtiyah M, Djanun Z, Tawilah JF, Aditama T, Thamlikitkul V, Vong S.

BMJ. 2017 Sep 5;358:j3808. doi: 10.1136/bmj.j3808. Review. No abstract available.

17.

Using information technology to improve surveillance of antimicrobial resistance in South East Asia.

Vong S, Anciaux A, Hulth A, Stelling J, Thamlikitkul V, Gupta S, Fuks JM, Walia K, Rattanumpawan P, Eremin S, Tisocki K, Sedai TR, Sharma A.

BMJ. 2017 Sep 5;358:j3781. doi: 10.1136/bmj.j3781. Review. No abstract available.

18.

Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.

Lenhard JR, Thamlikitkul V, Silveira FP, Garonzik SM, Tao X, Forrest A, Soo Shin B, Kaye KS, Bulitta JB, Nation RL, Li J, Tsuji BT.

J Antimicrob Chemother. 2017 May 1;72(5):1415-1420. doi: 10.1093/jac/dkx002.

19.

Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.

Rattanaumpawan P, Werarak P, Jitmuang A, Kiratisin P, Thamlikitkul V.

BMC Infect Dis. 2017 Mar 1;17(1):183. doi: 10.1186/s12879-017-2284-1.

20.

High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model.

Lenhard JR, Smith NM, Bulman ZP, Tao X, Thamlikitkul V, Shin BS, Nation RL, Li J, Bulitta JB, Tsuji BT.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01268-16. doi: 10.1128/AAC.01268-16. Print 2017 Mar.

21.

Dosing guidance for intravenous colistin in critically-ill patients.

Nation RL, Garonzik SM, Thamlikitkul V, Giamarellos-Bourboulis EJ, Forrest A, Paterson DL, Li J, Silveira FP.

Clin Infect Dis. 2017 Mar 1;64(5):565-571. doi: 10.1093/cid/ciw839. Epub 2016 Dec 23.

22.

Thailand Antimicrobial Resistance Containment and Prevention Program.

Thamlikitkul V, Rattanaumpawan P, Boonyasiri A, Pumsuwan V, Judaeng T, Tiengrim S, Paveenkittiporn W, Rojanasthien S, Jaroenpoj S, Issaracharnvanich S.

J Glob Antimicrob Resist. 2015 Dec;3(4):290-294. doi: 10.1016/j.jgar.2015.09.003. Epub 2015 Oct 14.

PMID:
27842876
23.

Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.

Harris PNA, McNamara JF, Lye DC, Davis JS, Bernard L, Cheng AC, Doi Y, Fowler VG Jr, Kaye KS, Leibovici L, Lipman J, Llewelyn MJ, Munoz-Price S, Paul M, Peleg AY, Rodríguez-Baño J, Rogers BA, Seifert H, Thamlikitkul V, Thwaites G, Tong SYC, Turnidge J, Utili R, Webb SAR, Paterson DL.

Clin Microbiol Infect. 2017 Aug;23(8):533-541. doi: 10.1016/j.cmi.2016.10.023. Epub 2016 Nov 1. Review.

24.

Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency.

Thamlikitkul V, Dubrovskaya Y, Manchandani P, Ngamprasertchai T, Boonyasiri A, Babic JT, Tam VH.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01337-16. doi: 10.1128/AAC.01337-16. Print 2017 Jan.

25.

Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii.

Lenhard JR, Gall JS, Bulitta JB, Thamlikitkul V, Landersdorfer CB, Forrest A, Nation RL, Li J, Tsuji BT.

Int J Antimicrob Agents. 2016 Dec;48(6):719-724. doi: 10.1016/j.ijantimicag.2016.07.024. Epub 2016 Sep 20.

26.

Epidemiology and economic impact of health care-associated infections and cost-effectiveness of infection control measures at a Thai university hospital.

Rattanaumpawan P, Thamlikitkul V.

Am J Infect Control. 2017 Feb 1;45(2):145-150. doi: 10.1016/j.ajic.2016.07.018. Epub 2016 Sep 21.

PMID:
27665034
27.

High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.

Lenhard JR, Bulitta JB, Connell TD, King-Lyons N, Landersdorfer CB, Cheah SE, Thamlikitkul V, Shin BS, Rao G, Holden PN, Walsh TJ, Forrest A, Nation RL, Li J, Tsuji BT.

J Antimicrob Chemother. 2017 Jan;72(1):153-165. Epub 2016 Sep 15.

28.

Epidemiology and burden of multidrug-resistant bacterial infection in a developing country.

Lim C, Takahashi E, Hongsuwan M, Wuthiekanun V, Thamlikitkul V, Hinjoy S, Day NP, Peacock SJ, Limmathurotsakul D.

Elife. 2016 Sep 6;5. pii: e18082. doi: 10.7554/eLife.18082.

29.

Oral Candida Colonization in Thai Patients with Psoriasis.

Chularojanamontri L, Wongpraparut C, Tuchinda P, Winayanuwattikun W, Boonyasiri A, Kulthanan K, Thamlikitkul V.

J Med Assoc Thai. 2016 Jan;99(1):84-7.

PMID:
27455829
30.
31.

Prevalence of Cutaneous Bacterial Colonization in Thai Patients with Psoriasis.

Chularojanamontri L, Wongpraparut C, Tuchinda P, Winayanuwattikun W, Boonyasiri A, Kulthanan K, Thamlikitkul V.

J Med Assoc Thai. 2016 Apr;99(4):418-23.

PMID:
27396227
32.
34.

Epidemiology of Antibiotic Use and Antimicrobial Resistance in Selected Communities in Thailand.

Khamsarn S, Nampoonsak Y, Busamaro S, Tangkoskul T, Seenama C, Rattanaumpawan P, Boonyasiri A, Thamlikitkul V.

J Med Assoc Thai. 2016 Mar;99(3):270-5.

PMID:
27276737
35.

Emergence and Dissemination of ST131 Escherichia coli Isolates Among Patients with Hospital-Acquired Pneumonia in Asian Countries.

Cha MK, Kang CI, Kim SH, Thamlikitkul V, So TM, Ha YE, Chung DR, Peck KR, Song JH.

Microb Drug Resist. 2017 Jan;23(1):79-82. doi: 10.1089/mdr.2016.0009. Epub 2016 Apr 20.

PMID:
27096168
36.

In vitro activity of Tedizolid phosphate against multidrug-resistant Streptococcus pneumoniae isolates from Asian countries.

Baek JY, Kang CI, Kim SH, Ko KS, Chung DR, Peck KR, Hsueh PR, Thamlikitkul V, So TM, Lee NY, Song JH; ANSORP Study Group.

Diagn Microbiol Infect Dis. 2016 Jun;85(2):218-20. doi: 10.1016/j.diagmicrobio.2016.02.022. Epub 2016 Mar 2.

PMID:
27083121
37.

Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.

Tsuji BT, Landersdorfer CB, Lenhard JR, Cheah SE, Thamlikitkul V, Rao GG, Holden PN, Forrest A, Bulitta JB, Nation RL, Li J.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):3913-20. doi: 10.1128/AAC.02831-15. Print 2016 Jul.

38.

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.

Maifiah MH, Cheah SE, Johnson MD, Han ML, Boyce JD, Thamlikitkul V, Forrest A, Kaye KS, Hertzog P, Purcell AW, Song J, Velkov T, Creek DJ, Li J.

Sci Rep. 2016 Feb 29;6:22287. doi: 10.1038/srep22287.

39.

Effectiveness of Chlorhexidine Wipes for the Prevention of Multidrug-Resistant Bacterial Colonization and Hospital-Acquired Infections in Intensive Care Unit Patients: A Randomized Trial in Thailand.

Boonyasiri A, Thaisiam P, Permpikul C, Judaeng T, Suiwongsa B, Apiradeewajeset N, Fakthongphan T, Suddee S, Laoagtipparos W, Thamlikitkul V.

Infect Control Hosp Epidemiol. 2016 Mar;37(3):245-53. doi: 10.1017/ice.2015.285.

PMID:
26894621
40.

Perception, Attitude, and Knowledge Regarding Antimicrobial Resistance, Appropriate Antimicrobial Use, and Infection Control Among Future Medical Practitioners: A Multicenter Study.

Chuenchom N, Thamlikitkul V, Chaiwarith R, Deoisares R, Rattanaumpawan P.

Infect Control Hosp Epidemiol. 2016 May;37(5):603-5. doi: 10.1017/ice.2016.8. Epub 2016 Jan 26.

PMID:
26809753
41.

Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand.

Thamlikitkul V, Tiengrim S, Seenama C.

Int J Antimicrob Agents. 2016 Jan;47(1):101-2. doi: 10.1016/j.ijantimicag.2015.11.006. Epub 2015 Dec 11. No abstract available.

PMID:
26725031
42.

Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?

Nation RL, Garonzik SM, Li J, Thamlikitkul V, Giamarellos-Bourboulis EJ, Paterson DL, Turnidge JD, Forrest A, Silveira FP.

Clin Infect Dis. 2016 Mar 1;62(5):552-558. doi: 10.1093/cid/civ964. Epub 2015 Nov 25.

43.

A Cluster-Randomized Controlled Trial of the Catheter Reminder and Evaluation Program.

Rattanaumpawan P, Teeratorn N, Thamlikitkul V.

Infect Control Hosp Epidemiol. 2016 Feb;37(2):231-3. doi: 10.1017/ice.2015.262. Epub 2015 Oct 23. No abstract available.

PMID:
26493352
44.

Implementation of antibiotic use guidelines for fresh traumatic wound at Siriraj Hospital.

Sirijatuphat R, Choochan T, Siritongtaworn P, Sripojtham V, Thamlikitkul V.

J Med Assoc Thai. 2015 Mar;98(3):245-52.

PMID:
25920294
45.

Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity.

Sirijatuphat R, Limmahakhun S, Sirivatanauksorn V, Nation RL, Li J, Thamlikitkul V.

Antimicrob Agents Chemother. 2015;59(6):3224-32. doi: 10.1128/AAC.00280-15. Epub 2015 Mar 23.

46.

In vitro and in vivo activity of tebipenem against ESBL-producing E. coli.

Thamlikitkul V, Lorchirachoonkul N, Tiengrim S.

J Med Assoc Thai. 2014 Dec;97(12):1259-68.

PMID:
25764632
47.

In vitro activity of polymyxin B against carbapenem-resistant Acinetobacter baumannii.

Thamlikitkul V, Tiengrim S, Seenama C.

J Med Assoc Thai. 2014 Dec;97(12):1254-8.

PMID:
25764631
48.

Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.

Jitmuang A, Nation RL, Koomanachai P, Chen G, Lee HJ, Wasuwattakul S, Sritippayawan S, Li J, Thamlikitkul V, Landersdorfer CB.

J Antimicrob Chemother. 2015;70(6):1804-11. doi: 10.1093/jac/dkv031. Epub 2015 Feb 18.

PMID:
25698772
49.

Prevalence and characteristics of Streptococcus pneumoniae "putative serotype 6E" isolates from Asian countries.

Baek JY, Park IH, So TM, Lalitha MK, Shimono N, Yasin RM, Carlos CC, Perera J, Thamlikitkul V, Hsueh PR, Van PH, Shibl AM, Song JH, Ko KS.

Diagn Microbiol Infect Dis. 2014 Dec;80(4):334-7.

PMID:
25439447
50.

High burden of antimicrobial drug resistance in Asia.

Lai CC, Lee K, Xiao Y, Ahmad N, Veeraraghavan B, Thamlikitkul V, Tambyah PA, Nelwan RH, Shibl AM, Wu JJ, Seto WH, Hsueh PR.

J Glob Antimicrob Resist. 2014 Sep;2(3):141-147. doi: 10.1016/j.jgar.2014.02.007. Epub 2014 Mar 28. Review.

PMID:
27873720

Supplemental Content

Loading ...
Support Center